Intelligent Bio Solutions Inc. (NASDAQ:INBS) on Wednesday announced that Managed Waste Service plans to implement INBS' Intelligent Fingerprinting Drug Screening System across its New South Wales ...

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, non-invasive drug screening ...

NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), today announced that Boughey Distribution (“Boughey”), one of the United Kingdom’s leading ...

NEW YORK, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...

Intelligent Bio Solutions partners with Spjotgard to enhance fingerprint drug testing adoption in Scandinavia, addressing rising demand for non-invasive solutions. Intelligent Bio Solutions Inc.

Lab-testing pathway to expand capabilities of proprietary drug test screening to detect potent opioid fentanyl and fentanyl-adulterated street drugs Opioid crisis estimated to be costing the U.S. $1.5 ...

INBS to participate with U.S. distribution partner SMARTOX at RISE25, the leading U.S. conference on addiction, mental health, and justice innovation which draws over 7,000 attendees annually With ...

Quantum TM adopts INBS’ fingerprint drug testing for faster, more efficient workplace screening across 10 UK sites. INBS plans US expansion in 2025 after FDA submission, aiming to tap into the growing ...

NEW YORK, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the "Company”), a life sciences company delivering intelligent, non-invasive, real-time testing solutions, ...